Immunological findings in patients with chronically recurrent vaginal candidosis and new therapeutic approaches

Mycoses. 1989 Aug;32(8):386-90. doi: 10.1111/j.1439-0507.1989.tb02268.x.

Abstract

Eighteen patients with chronically recurrent vaginal candidosis showed low T-lymphocyte counts twice as frequent as a control group of 55 women. The patients were treated with azoles locally and lymphocyte stimulating pentapeptide thymopentin. The prolongation of disease-free intervals and a cure was mainly seen in the patients with low T-cell values before therapy. In vitro-proliferation assays upon stimulation with Candida albicans bore no correlation with the course of the disease. We suspect a failure in the co-operation of the immune cells, caused by differing strong responses to the Candida albicans stimulation.

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Candidiasis, Vulvovaginal / drug therapy
  • Candidiasis, Vulvovaginal / immunology*
  • Chronic Disease
  • Female
  • Humans
  • Leukocyte Count
  • Lymphocyte Activation
  • Peptide Fragments / therapeutic use
  • Recurrence
  • T-Lymphocytes / immunology*
  • Thymopentin
  • Thymopoietins / therapeutic use

Substances

  • Adjuvants, Immunologic
  • Peptide Fragments
  • Thymopoietins
  • Thymopentin